Familial amyloid polyneuropathy
| Familial amyloid polyneuropathy | |
|---|---|
| Other names | FAP, hereditary transthyretin amyloidosis (hATTR), Corino de Andrade's disease | 
| Familial amyloid polyneuropathy has an autosomal dominant pattern of inheritance. | |
| Specialty | Neurology | 
| Diagnostic method | Genetic testing | 
| Medication | Tafamidis, patisiran | 
Familial amyloid polyneuropathy, also called hereditary transthyretin amyloidosis (hATTR), or Corino de Andrade's disease, is an autosomal dominant neurodegenerative disease. It is a form of amyloidosis, and was first identified and described by Portuguese neurologist Mário Corino da Costa Andrade, in 1952. FAP is distinct from senile systemic amyloidosis (SSA), which is not inherited, and which was determined to be the primary cause of death for 70% of supercentenarians who have been autopsied. FAP can be ameliorated by liver transplantation.